论文部分内容阅读
美国塞普拉柯(Seoracor)公司的酒石酸阿福特罗(afromoterol tartrate)吸入液(商品名:Brovana)于2006年10月在美国获准上市,用于长期维持治疗慢性阻塞性肺病(COPD)引起的支气管收缩症状,包括慢性支气管炎和肺气肿。该药的化学名为N-[2-羟基-5-[(1R)-1-羟基-2-[[(1R)-2-(4-苯甲氧
US company Seoracor afromoterol tartrate inhalation solution (trade name: Brovana) was approved in the United States in October 2006 for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) Bronchoconstriction symptoms, including chronic bronchitis and emphysema. The drug’s chemical name is N- [2-hydroxy-5 - [(1R) -1 -hydroxy- 2 - [[(1R) -2-